Resources
About Us
Meticulous Research—a leading global market research company, published a research report titled ‘Compression Therapy Market Size, Share, Forecast, & Trends Analysis by Product (Bandages, Stockings, Tapes, Pumps) Technique (Static, Dynamic) Condition (Varicose Vein, Lymphedema, Leg Ulcer) Distribution (E-commerce, Hospital) – Global Forecast to 2030.’
According to this latest publication from Meticulous Research, the compression therapy market is expected to reach $5.88 billion by 2030, at a CAGR of 3.8% from 2024 to 2030.The growth of this market is primarily driven by the rising global geriatric population, the increasing prevalence of chronic diseases, the growing number of sports and accident injuries, the growth in orthopedic procedures, the increasing cases of varicose veins and Deep Vein Thrombosis (DVT), the growing acceptance of compression therapy products as a preventive measure, and the minimal side effects and wide-ranging advantages of compression therapy. However, the lack of adherence to compression therapy among patients, the high costs of compression therapy garments, and the lack of awareness regarding compression therapy restrain the market’s growth.
Furthermore, emerging economies are expected to offer significant growth opportunities for the players operating in this market. However, the adoption of alternative technologies and an inadequate reimbursement structure for compression therapies are major challenges impacting market growth.
Key Players
The key players operating in the compression therapy market include 3M Company (U.S.), Essity Aktiebolag (publ) (Sweden), Bio Compression Systems, Inc. (U.S.), Arjo AB (Sweden), Convatec Inc. (U.S.), Cardinal Health, Inc. (U.S.), PAUL HARTMANN AG (Germany), Medline Industries, Inc. (U.S.), Julius Zorn, Inc. (U.S.), DJO, LLC (U.S.), Smith & Nephew plc (U.K.), medi GmbH & Co. KG (Germany), and SIGVARIS AG (Switzerland).
Compression Therapy Market: Future Outlook
The compression therapy market is segmented by Product [Bandages, Garments (Stockings {Class I, Class II, Class II}, Socks & Sleeves, Wraps & Tapes, and Other Garments), Intermittent/Sequential Pneumatic Compression Pumps (Non-segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps), and Other Pressure Pumps], Technique [Static Compression Therapy and Dynamic Compression Therapy], Condition [Varicose Veins, Deep Vein Thrombosis, Lymphedema, Leg Ulcers, and Other Conditions], Distribution Channel [Hospitals & Clinics, Pharmacies & Retailers, E-commerce, and Other Distribution Channels], Facility (Healthcare Providers, Home-care Settings), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Among all products covered in this report, in 2024, the garments segment is expected to account for the largest share of the compression therapy market. The large market share of this segment is primarily attributed to the widespread adoption of compression therapy garments for edema and venous disorders. Additionally, some compression therapy garments are readily available off the shelf and are in high demand due to the increasing prevalence of conditions like varicose veins, chronic edema, and lymphedema among the geriatric population.
Among all techniques covered in this report, in 2024, the static compression therapy segment is expected to account for the larger share of the compression therapy market. The large market share of this segment is attributed to the widespread adoption of static compression therapy due to its benefits, including enhanced comfort during extended use, cost-effectiveness, user-friendly application, and reliable delivery of consistent pressure.
Among all conditions covered in this report, in 2024, the varicose veins segment is expected to account for the largest share of the compression therapy market. The large market share of this segment can be attributed to the increasing prevalence of varicose vein-related disorders among the elderly population, advancements in vein-specific compression therapeutic devices, and the growing number of obese individuals who are at a higher risk of developing varicose veins.
Among all distribution channels covered in this report, in 2024, the pharmacies & retailers segment is expected to account for the largest share of the compression therapy market. The large market share of this segment is attributed to the growing demand for compression therapy products and their wide accessibility through pharmacies that operate around the clock.
Among all facilities covered in this report, in 2024, the healthcare providers segment is expected to account for the larger share of the compression therapy market. The large market share of this segment is attributed to healthcare providers' increasing recommendation of using compression therapy solutions for people at risk of deep vein thrombosis and obesity, and the use of compression solutions in the management of chronic venous insufficiency.
Geographic Review
This research report analyzes major geographies and provides a comprehensive analysis of the compression therapy market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the compression therapy market. North America’s significant market share can be attributed to several factors, including the growing elderly population, high healthcare expenditures, the rising number of individuals with chronic conditions, and the presence of major market players in the region. According to the U.S. Census Bureau and Population Estimates and Projections, the geriatric population in the U.S. is expected to surpass 80 million by 2040, up from 56.1 million in 2020. This demographic shift is increasing the incidence of chronic diseases such as diabetes and vein-related disorders, driving the demand for home-care treatments and targeted therapies.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5640
Key Questions Answered in the Report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Dental Lasers Market to be Worth $618.7 million by 2031
Read MoreBakuchiol Serum Market to Reach $4.41 Million by 2031
Read MoreBurn Care Market to be Worth $4.32 Billion by 2031
Read MoreAfrica Medical Devices Market to be Worth $7.14 Billion by 2031
Read MoreMiddle East Medical Devices Market to be Worth $8.8 Billion by 2031
Read MoreSurgical Drills Market to be Worth $1.71 Billion by 2031
Read MoreTissue Engineering Market to reach $7.41 Billion by 2031
Read MoreDental Prosthetics Market to be Worth $ 19.6 Billion by 2031
Read MoreWhole Genome Sequencing Market to be Worth $7.17 Billion by 2031
Read MoreIVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MoreViral Vaccines Market to be Worth $64.18 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreU.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreDigital Therapeutics Market to be Worth $56.34 Billion by 2031
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MoreTask Trainers Market to Be Worth $2.9 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More